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Background and aims: Today, the prevalence of structural and functional disorders of sperm and subsequently the possibility of occurrence 
of autism, spontaneous abortion, and infertility has increased dramatically. This study aimed to investigate the potential effects of myo-
inositol and N-acetyl-L-cysteine (NAC) on the improvement of processed spermatozoa indices.
Methods: In this study, 63 patients with male factor infertility were studied in Hazrat Zahra Infertility Center of Shahrekord. To do 
liquefaction, the semen sample was incubated at 37°C for 20 minutes. The Density Gradient Centrifugation protocol was used to process 
sperm. The processed sperm samples were incubated at 37°C for 20 minutes in four groups of control, myo-inositol (2 mg/mL), NAC 
antioxidant (10 Mm/L) and myo-inositol+NAC. All biological parameters of sperm were evaluated using Makler slide, SQA-V sperm 
analyzer gold version 2.48, TUNEL assay, and Toluidine blue staining.
Results: In the present study, 63 men aged 22-58 years with infertility complaints were studied. The NAC group and the myo-inositol group 
exhibited significantly higher motility in comparison with the control group (P < 0.001). The NAC group also had a significantly higher 
number of TUNEL-negative cells and a lower number of TUNEL-positive cells than the control group (P < 0.01), but in other variables, the 
differences were not statistically significant. The morphology, S0, S1, S2 and staining types in the intervention groups did not show any 
significant difference compared to those in the control group (P > 0.05).
Conclusion: NAC and myo-inositol were able to improve certain indices such as sperm motility and integrity; therefore, the quality of 
sperm could be improved by these drugs to treat infertility.
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Introduction 
Today, infertility has become one of the main concerns of 
the community, especially medical circles (1). According 
to the statistics provided by Avicenna Research Institute 
(obtained from a study on 17 000 couples over a 2-year 
period), the prevalence of infertility in Iran is estimated 
to be 20.2% (almost twice the global average declared by 
the WHO). Evidence has revealed that 40% of the cases of 
infertility are due to male factors, 40% are due to female 
factors, 10% are due to both and 10% of infertility cases 
are due to unknown causes (1). Although the molecular 
basis of idiopathic infertility remains to be elucidated, it 
seems that high level of reactive oxygen species (ROS) 
in semen plasma is one of the most important causes of 
idiopathic infertility. It should be noted that low and 
normal concentrations of ROS in semen plasma (hydrogen 
peroxidase or free radicals such as nitric and anion 
peroxidase) stimulate and improve sperm capacitation 
process, increase sperm activity, induce acrosome reaction, 
increase the sperm ability to bind to the zona pellucida and 
ultimately lead to fertility (2,3). At sperm capacitation, 
high levels of ROS and high concentrations of intracellular 
calcium and tyrosine kinase lead to an increase in cAMP 
and consequently improve sperm motility (2,4). High 
concentrations of ROS disrupt the structure of DNA, 
eliminate the integrity of the DNA structure, reduce the 
sperm motility, disrupt the integrity of the cytoplasmic 
membrane structure of the sperm and cause a reduction 
in the fertility potential of the sperm. Regarding the 
existence of a direct and significant relationship between 
the deficiency of antioxidants and infertility due to male 
factors, the use of some antioxidants such as N-acetyl-
L-cysteine (NAC), coQ10, L-carnitine, zinc, selenium, 
and vitamins C and E, which reduce ROS and increase 
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fertility, is recommended for the treatment of male factor 
infertility (3).
NAC is one of the most powerful antioxidants with 
positive effects on fertility. This compound can directly 
scavenge the free radicals of oxygen and cause the survival 
of spermatogonia germ cells in the seminiferous tubules, an 
increase in sperm motility, a significant decrease in ROS 
levels in semen plasma, an increase in sperm chromatin 
density, and a decrease in sperm fragmentation (4,5). NAC 
has been shown to reduce the cytoplasmic reticulum stress 
by inhibiting ROS in Sertoli cells. This compound reduces 
lipid peroxidation, preserves the cell structure, especially 
Sertoli cells, and maintains their function (6).
Infertility treatment studies have shown the role of 
oral myo-inositol in morphogenesis, lipid synthesis, cell 
cytogenesis, and biological characteristics of sperm and 
fertility (4,7). Myo-inositol is one of the nine isomers of 
inositol and belongs to group B vitamins. Myo-inositol 
is one of the synthesis precursors of phosphatidylinositol 
polyphosphate, and as a second messenger precursor, 
plays an important role in regulating intracellular calcium 
levels, regulating sperm motility, increasing sperm 
capacitation, maintaining mitochondrial membrane 
potential, integrating the cellular skeletal system, regulating 
gene expression, regulating the lipid content of sperm 
cytoplasmic membrane, and producing acrosome reaction 
(2,8-10). Studies have shown that myo-inositol plays a 
crucial role in sperm maturation and migration of cells 
from the epididymis and its concentration is higher in the 
seminiferous tubule fluids than in semen plasma (11,12). It 
also plays an important role in chemotaxis including human 
sperm chemotaxis through the activation of phospholipase 
C, which leads to the production of InsP3, opening of 
calcium channels, and increase of intracellular calcium 
concentrations in sperm flagellum (12). This drug is 
commonly used for the treatment of male factor infertility, 
with promising results reported on the improvement of 
semen quality by using it.
Given the increasing prevalence of male factor infertility, 
the increase in the need for modern methods of infertility 
treatment, efforts to increase the quality of sperm 
processed for intrauterine insemination (IUI) or in vitro 
fertilization/intracytoplasmic sperm injection (IVF/ICSI), 
and the necessity of using drug compounds to improve 
sperm fertility indexes and chromatin health, this study 
was done to investigate the effect of myo-inositol (2 mg/
mL), NAC (10 mmol/L) and NAC + myo-inositol (2 mg/
mL, 10 mmol/L) on sperm fertility. Since sperm selection 
according to normal biological parameters cannot indicate 
the sperm DNA integrity (13) and there is no correlation 
between the biological parameters of sperm and the severity 
of DNA damage (14), the effect of these compounds on 
the rate of DNA damage and chromosomal health of the 
sperm was also examined.
Materials and Methods
This clinical trial was conducted during 2018-2019 at 
Shahrekord University of Medical Sciences and its protocol 
was approved by the Deputy of Research and Technology 
of the University and registered in the Iranian Registry of 
Clinical Trials (identifier:  IRCT20190204042618N2). 
To select participants, convenience sampling was 
done in male patients referring to the Infertility Center 
in Shahrekord. Assuming that during the study, each 
qualitative parameter of the sperm changed by at least half 
of the standard deviation, the sample size was determined 
to be at least 63 individuals based on a confidence level of 
95% and power of 80% (8) (It should be noted that the 
samples obtained from these individuals are divided into 4 
sections after processing).
In this study, 63 patients  with male factor infertility, the 
history of infertility for at least 12 months, spermatozoa 
count of less than 106×15/mL, progressive motility of less 
than 32%, and normal morphology of less than 4% were 
included. Additionally, patients who consumed alcohol, 
minerals, multivitamin or any fertility enhancer in the last 
three months or used unauthorized compounds and drugs 
were excluded.
Patients’ characteristics such as age, weight, body mass 
index, occupation, marriage duration, years of infertility, 
smoking habits, alcohol and drug use, physical activity, 
chemical exposure, and history of disease or surgery were 
recorded. Before participating in the study, the patients 
signed the consent form. The samples were recorded 
anonymously and the samples’ specifications were 
determined only by a computer code. After semen samples 
were received under standard conditions in sterile plastic 
containers and were sent to the laboratory, they were 
incubated at 37°C for 20 minutes for liquefaction.
The Density Gradient Centrifugation protocol was 
used to process sperm. After sperm preparation by this 
technique, all of the biological parameters of the sperm 
(viability of sperm, normal morphology, and total motile 
count) were evaluated using Makler slides (phase contrast 
microscope) and SQA-V sperm analyzer gold version 2.48. 
Then, the processed sperm sample was divided into four 
parts as follows: 
1) Control group: One part of the sample with no 
exposure to drugs was incubated for 20 minutes at 
37°C. 
2) Treatment group 1: One part of the sample was 
incubated with 2 mg/mL of myo-inositol at 37°C for 
20 minutes.
3) Treatment group 2: One part was exposed to the NAC 
antioxidant (10 mM/L) and incubated at 37°C for 20 
minutes (16).
4) Treatment group 3: The last portion of the sperm 
sample was exposed to myo-inositol (2mg/mL) + NAC 
(10 mM/L) and incubated at 37°C for 20 minutes 
under the same conditions as the previous ones. 
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After the completion of the incubation period in all groups, 
the biological parameters of the sperm were evaluated and 
recorded by an andrology specialist.
Calculating total motile sperm count
Using a macroscopic technique, a volume of 10 μL of 
semen sample was left in a counting chamber at room 
temperature. Immediately after placing the sample in the 
chamber and preparing it, the number and motility of the 
sperm were determined and the number of motile and 
immotile spermatozoa was reported as a percentage.
Papanicolaou staining
To evaluate the specific characteristics of cell structure 
and sperm morphology and accurate examination of the 
sperm head, middle piece and tail defects, a thin smear was 
prepared from the samples of the control and treatment 
groups and then evaluated by Papanicolaou staining. In 
this method, after washing the semen sample with AllGrad 
Wash (three times, each time for 5 minutes) and preparing 
smear, hematoxylin was applied to the samples for 3 
minutes. Then, the slides were dehydrated and stained 
with OG. Ultimately, after rehydrating the slides with 
different concentrations of alcohol, we used 50A12 stain, 
and after drying and mounting the slides, evaluations were 
performed at 40X and 100X magnifications. In this study, 
head defects (acrosome structures), neck defects (structure 
of the sperm neck and cytoplasmic droplets), and tail 
defects (coiled, double, and short tails) were investigated.
Toluidine blue staining
Similarly, to evaluate the chromosomal structure of the 
sperm, a thin smear was prepared from different groups and 
stained with Toluidine blue. In this method, 96% ethanol 
acetone fixation was used (1:1 ratio), and after drying 
the slides, HCl was used for 5 minutes at 4°C to conduct 
hydrolysis. Then, the slides were washed several times by 
washing medium and admixed with Toluidine blue at a 
concentration of 1% and pH 3.5. In order to make the 
smears transparent, they were placed in a jar containing 
xylene at room temperature for 5 minutes. Finally, after 
mounting the slides, they were evaluated at 40X and 100X 
magnifications. The indexes measured in this staining 
method include S0, S1 and S2, which are defined as follows:
• S0 contains healthy and intact spermatozoa that appear 
in bright blue or bright purple.
• S1 contains unhealthy spermatozoa that can appear 
semi-colored.
• S2 contains abnormal spermatozoa that appear in 
extremely dark purple.
TUNEL assay
In TUNEL assay, a thin smear of unprocessed (control) 
and processed (target groups) sperm cells was prepared 
and fixed with paraformaldehyde for one hour. After 
placing the prepared smears in the permeable solution 
and washing them with phosphate buffer saline (PBS), 
staining was carried out according to the instructions of the 
TUNEL assay kit (Roche, 11684817910). The evaluation 
of the prepared slides and examinations of positivity and 
negativity of the cells were performed using a fluorescence 
microscope at 510 nm.
Sperm with a normal chromosomal structure and 
undamaged and dense chromatin appeared in green, 
whereas sperm with damaged DNA and chromosome 
appeared in yellowish green color. In each slide, 100 sperms 
were counted and the percentages of normal and abnormal 
sperms were calculated.
Statistical analysis 
The data were entered into the SPSS and GraphPad software. 
The normally distributed quantitative variables were 
expressed as mean ± SD, and non-normally distributed 
quantitative variables were expressed as the median with 
interquartile range. Additionally, qualitative variables were 
expressed as frequency  and percentage. The comparison of 
variables in groups was performed by Friedman test followed 
by Dunn’s test. P < 0.05 was considered significance level.
Results
In this study, a total of 63 male individuals aged 22 to 58 
years were enrolled. The infertility period, weight, height, 
and body mass index of patients are shown in Table 1.
The rates of motility and normal morphology of sperm 
in the studied groups are shown in Table 2. Motility rate 
in the control group significantly changed after sperm 
processing according to the results of Density Gradient 
Centrifugation (P < 0.001). It should be noted that sperm 
Table 1. Characteristics of the patients studied
Variable Minimum Maximum Mean ± SD
Age (y) 22 58 7.2 ± 35.1
Infertility period (y) 1 27 5.75 ± 6.43
Weight (kg) 58 110 9.9 ± 78.1
Height (cm) 165 189 5.34 ± 177.02
Body mass index 19.3 34.3 2.56 ± 24.9
Table 2. Motility and morphology of patients 
Variable Before intervention
Studied groups
Control NAC Myo NAC+Myo
Motility 30.8 (26-35) 45 (35-50) 50 (40-55) 47 (40-55) 45 (35-50)
Morphology 2.5 (2.1-3) 6 (5-7) 6 (5.1-7) 6 (5-7) 5.9 (5-6.9)
Data are presented as median (interquartile range).
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with better motility and morphology are separated by 
Density Gradient Centrifugation. In the NAC group, 
motility showed a significant difference compared to 
the control group (P < 0.001). The myo-inositol group 
showed a significant difference in motility compared 
to the control group (P < 0.001). Normal morphology 
rate was significantly higher in the control group after 
sperm processing according to the Density Gradient 
Centrifugation results (P < 0.001), but control, NAC, 
Myo-inositol, and NAC + Myo-inositol groups did not 
significantly differ in this variable (P = 0.063) (Figure 1).
According to the results of toluidine blue staining and 
chromatin density evaluation, there was no significant 
difference in S0, S1, and S2 between the experimental groups 
(P = 0.082) (Figures 2 and 3).
According to the results of TUNEL assay, there was a 
significant difference between the NAC and the control 
group, indicating that the number of sperm cells that 
had negative TUNEL staining was higher in the NAC 
group (P = 0.004) and conversely, the number of TUNEL-
positive cells was significantly lower in this group than in 
the control group (P = 0.004). There was no significant 
difference between the other groups (P = 0.281) (Figure 4).
In testing viability by Trypan blue staining based on the 
membrane responsiveness of the cells to the permeable 
staining materials, there was no significant difference 
between the experimental groups (P = 0.312) (Figure 5).
After Papanicolaou staining, the control group did not 
show any significant difference in sperm head morphology 
(including normal, big and small head) and sperm tail 
morphology (including coil, double and short tail), and 
cytoplasmic droplet after sperm processing according to the 
results of density gradient centrifugation. There was also 
no significant difference between the experimental groups 
(P = 0.159) (Figures 6 and 7).
Discussion
In the present study, the effect of myo-inositol and NAC 
and their combination on the improvement of the quality 
and quantity of the processed spermatozoa for use in 
modern methods of fertility treatment (IVF/ICSI) was 
evaluated at Hazrat Zahra Infertility Center of Shahrekord. 
For this purpose, a total of 63 men aged 22 to 58 years were 
enrolled in the study.
In this study, the NAC and myo-inositol group showed 
significantly higher motility than the control group. The 
number of TUNEL-negative cells was also significantly 
higher in the NAC group compared to the control group 
and the number of TUNEL-positive cells was significantly 
lower in the NAC group than in the control group, but 
other groups did not show any significant difference in 
these two factors. The rate of normal morphology, S0, S1, 
and S2 as well as the results of different staining methods in 
intervention groups did not show any significant difference 
compared to those in the control group.
In the study by Comhaire et al, the effect of oral 
antioxidants (3-month treatment with NAC 600 mg 
and vitamins A+E) and essential fatty acids was studied 
on sperm biology in infertile men. In that study, the 
Figure 1. Normal Morphology and Motility Rate in the Studied 
Groups.
Figure 2. Toluidine blue staining and S0, S1, and S2 sperms.
Figure 3. S0, S1, and S2 in the studied groups.
Figure 4. TUNEL assay. (A) The Bright Green Cells Show the 
TUNEL-positive Cells with Damaged Chromatin; (B) Percentage of 
TUNEL-negative Cells; and (C) Percentage of TUNEL-positive Cells 
in the Studied Groups
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improvement of sperm parameters, decrease in ROS and 
8-OH-Dg (oxidized DNA of the sperm), increase in 
acrosome reaction and spermatozoa membrane fluidity 
after drug administration were not significant. The total 
number of sperm increased from 7.4 million to 12.5 
million. The pregnancy rate of patients who used the 
sperm exposed to these compounds reached 4.5%. In this 
study, the motility and normal morphology rate of sperm 
did not change significantly (15). The results of this study 
are consistent with the present study because NAC did 
not affect morphology, although in the present study, in 
vitro exposure to these drugs lasted only 20 minutes, which 
is different from exposure through oral and long-term 
administration.
Oeda et al used NAC to reduce ROS in human semen 
samples. The amount of ROS in semen plasma decreased 
significantly after the use of medication for 20 minutes. In 
addition, in this study, the total sperm motility significantly 
increased. The researchers recommended using NAC 
antioxidants to improve sperm function (16). The results 
of the present study on the increase of sperm motility in 
the NAC and myo-inositol groups are consistent with the 
results of the cited study (16).
Paradiso Galatioto et al observed a significant increase 
in spermatozoa count (up to 20 times) after oral treatment 
with 600 mg NAC and antioxidants (along with various 
vitamins and minerals). Treatment with antioxidants 
had no significant effect on total sperm motility, normal 
morphology, and rate of pregnancy (17). Condorelli 
et al studied the effect of myo-inositol on spermatozoa 
apoptosis and mitochondrial function of sperm in patients 
with oligo-terato-asthenozoospermia and reported that 
Figure 5. (A) Trypan Blue Staining. Arrows show the penetration 
of stain into the sperm cells and reduction of their viability; (B) 
Viability Rate in Different Groups.
Figure 6. Papanicolaou staining for the evaluation of sperm 
morphology.
Figure 7. Evaluation of sperm morphology using papanicolaou staining .
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the drug had no effect on the improvement of sperm 
mitochondria and its function. In this study, myo-inositol 
significantly increased the number of spermatozoa with 
high mitochondrial membrane potential. The number 
of spermatozoa with low mitochondrial membrane 
potential in patients with oligo-terato-asthenozoospermia 
also significantly reduced. Additionally, the drug had no 
significant effect on sperm chromatin density (18), which 
is consistent with our study.
Unfortunately, the prevalence of infertility in the 
world, especially in Iran, is increasing. According to the 
latest epidemiological study, the prevalence of infertility 
in Iran is much higher than global statistics and is 
estimated to be 20.2%. Approximately 40% of infertility 
is due to male factors, the most important of which are 
spermatic (oligospermia, teratospermia, asthenospermia, 
and azoospermia), anatomical, and hormonal disorders. 
Therefore, given the increasing prevalence of infertility 
in the male population of the country, the need for male 
fertility treatment has become one of the main priorities of 
all infertility treatment centers. The selection of a sufficient 
number of spermatozoa with normal biological parameters 
and the health of the genomic and chromosomal structure 
can have a direct and significant effect on the success rate 
of fertility treatments, fertilization rate, cleavage rate, 
number of fetuses, quality of the fetus, and ultimately 
pregnancy rate. Therefore, selecting the protocol for sperm 
preparation and optimization in assisted reproductive 
technology (ART) cycles, especially IUI, is of particular 
importance. It is worth noting that the use of antioxidants 
not only has direct effect on biological parameters of sperm 
such as number, motility, morphology, and agglutination 
rate but also can change the sperm capacitation and the 
rate of acrosome reaction in sperm by modifying all specific 
indexes of sperm fertility and ultimately affect the ability of 
the sperm to fertilize the ovum (19). In this regard, it has 
been reported that the use of antioxidant compounds in 
patients with oligospermia or asthenozoospermia, or those 
who have high levels of ROS (oxidative stress) in their 
samples can be a useful solution to prevent the oxidative 
effects of ROS on such processed spermatozoa.
The total number of spermatozoa reduced after the 
preparation process, because the sperm processing eliminates 
the dead, damaged and poorly motile spermatozoa and 
increases the number of appropriate sperm that are capable 
of fertilizing the ovum. Therefore, the reduction in the total 
number of spermatozoa is expected in all sperm preparation 
methods. In the present study, it was also observed that the 
sperm motility and morphology improved in the control 
group after processing and in the intervention groups 
compared to the control group, which is desirable given 
that the dead and damaged spermatozoa were eliminated. 
In the present study, as already mentioned, total sperm 
motility increased in all groups and the highest increase in 
sperm motility was observed in the NAC and myo-inositol 
groups.
Given the importance of the subject and the efforts to 
increase the quantity and quality of processed spermatozoa 
in ART techniques, many studies across the world have 
been conducted on sperm and its processing methods. The 
aim of this study was to increase the number of spermatozoa 
with normal morphological and chromosomal structures 
that have the potential to fertilize the ovum.
In the study of Montanino Oliva et al, the effect of myo-
inositol and antioxidants in men with spermatic dysfunction 
and metabolic disorders was shown to be greater in case of 
myo-inositol being used with other antioxidants (8).
As observed in our study, the motility rate increased in 
the NAC and myo-inositol groups. Besides, the number 
of TUNEL-negative cells was significantly higher in the 
NAC group than in the control group, and the number 
of TUNEL-positive cells was significantly lower in the 
NAC group than in the control group. In general, these 
effects can be due to the antioxidant effects of myo-inositol 
and NAC, and consequently, the prevention of adverse 
effects of ROS, which are consistent with the results 
reported by other researchers using other antioxidants 
and herbal compounds. In a study conducted by Barekat 
et al, the effect of NAC on the integrity of sperm DNA 
after varicocelectomy surgery was investigated and it was 
shown that oral administration of 200 mg NAC could 
significantly increase the integrity of sperm DNA in the 
case group compared to the control group (20), which 
confirms the results of the present study. In other studies, 
it has been observed that myo-inositol in sperm freezing 
significantly increases the progressive motility and normal 
morphology of sperm and also reduces DNA damage. This 
shows that myo-inositol will prevent destructive effects that 
usually occur after sperm freezing, which also confirms the 
results of the present study. It has also been suggested that 
myo-inositol can be used in fertility and andrology labs 
and sperm banks for infertile and cancer patients who 
refer for sperm cryopreservation. Companies that produce 
sperm cryopreservation kits can use this substance in their 
commercially available products.
Nazm Bojnordi et al studied the effect of antioxidants 
on melted and frozen human sperm quality and observed 
that in normal individuals, the addition of vitamin E at 
concentrations of 1 and 2 mM caused an increase in sperm 
motility, forward progression and survival rate, among which 
the increase in forward progression and survival rate was 
significant. This increase was also observed in individuals 
with oligospermia, but in general, there was no significant 
difference. Ascorbic acid had no significant effect on any 
of the sperm parameters (21). Overall, the results of the 
above-mentioned studies confirm the results of the present 
study on the positive effects of NAC and myo-inositol on 
maintaining the quality of processed spermatozoa. In this 
regard, it should be noted that during cryopreservation, 
semen is exposed to cold shock and osmotic pressure, 
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and as a result, the amount of oxidation of the membrane 
increases due to the higher percentage of oxidative reactions, 
which ultimately leads to decrease in sperm survival and 
longevity. Studies have shown that fertilization rates 
decrease significantly after sperm cryopreservation due to 
its inappropriate function. Cryopreservation also leads to 
changes in DNA, sperm cytoskeleton, inhibition of sperm-
egg binding, and destruction of sperm axoneme, leading 
to a reduction in motility. Therefore, the protection of the 
plasma membrane of the sperm against oxidative reactions 
is accomplished by antioxidants during cryopreservation. 
In the liquefaction stage, due to the presence of free radicals 
in the sperm medium, the destructive and oxidative effects 
of these agents on sperm are likely. In fact, antioxidants, by 
reducing the formation of free oxygen radicals, change the 
cellular conditions to preserve the sperm motility (22). In 
this regard, the protective effects of various antioxidants, 
including alpha-tocopherol, have been reported to maintain 
sperm quality parameters and increase its motility (23), 
which confirms the results of the present study.
Moreover, Papaleo et al studied the effect of myo-inositol 
on the quality of oocyte in intracytoplasmic sperm injection 
cycles with the cooperation of University of Scarborough, 
Canada. The researchers observed that treatment with 
myo-inositol and folic acid in patients with polycystic 
ovary syndrome (PCOS) reduced germinal vesicles and 
degenerated oocytes at ovum pick-up, while not affecting 
the total number of oocytes recovered. Therefore, this 
study showed the positive effect of myo-inositol on the 
maturation quality of the growing oocytes (24). These 
results are also consistent with the results of the present 
study on the positive effect of myo-inositol and NAC on 
improving the quality of processed spermatozoa. Caprio 
et al studied myo-inositol therapy for poor responders 
during IVF. In this study, 76 patients were divided into two 
groups, one group received myo-inositol and folic acid and 
the other group received only folic acid for three months. 
This study showed that myo-inositol had a positive effect 
on the quality and number of oocytes and could increase 
the response of the ovary to gonadotropins, and therefore, 
it can be used as an adjuvant therapy in poor responders 
during IVF (25). Taken together, these results support the 
use of medications such as NAC and myo-inositol due to 
their positive effects on sperm and ovum.
Conclusion
In the present study, NAC and myo-inositol were found to 
improve parameters such as sperm motility and integrity. 
Therefore, by using these drugs, especially NAC, sperms 
of higher quality can be provided to treat infertility. 
Therefore, it is suggested that in order to increase the 
efficacy of these compounds, the effects of other drug and 
antioxidant combinations, along with the subjects in this 
study, be investigated.
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